Breast cancers detected with imaging screening in the BRCA population: emphasis on MR imaging with histopathologic correlation

Radiographics : a Review Publication of the Radiological Society of North America, Inc
Petrina A CauserDonald B Plewes

Abstract

The benefit of screening with breast magnetic resonance (MR) imaging for certain patient populations at high risk for breast cancer, most notably patients with a genetic mutation in the BRCA1 or BRCA2 gene, has been established in numerous studies and is now becoming part of routine clinical practice. Despite the lower sensitivity of mammography compared with that of MR imaging, the former remains the standard of care for screening any patient population. In the BRCA1 and BRCA2 populations, the inferior sensitivity and specificity of ultrasonography (US) limit its role as a screening tool, but US remains a vital diagnostic tool because of its ability to provide guidance for biopsy of many suspicious lesions detected with MR imaging. Important features of a screening program with breast MR imaging include the following: optimization of the MR imaging technique, an awareness of the imaging features of invasive and noninvasive breast cancers detected with MR imaging, an understanding of the limitations of the various imaging modalities in both the initial screening and subsequent diagnostic work-up evaluations, and the requirement for MR imaging-guided biopsy.

References

Feb 1, 1984·Cancer·H T LynchC A Wagner
Mar 1, 1997·Radiology·L W NunesM H Torosian
Feb 1, 2000·Trends in Genetics : TIG·P L WelcshM C King
Jul 6, 2000·Journal of the National Cancer Institute·M T MandelsonE White
Feb 22, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C T BrekelmansUNKNOWN Rotterdam Committee for Medical and Genetic Counseling
Apr 27, 2001·Radiology·L W NunesS G Orel
Mar 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lauren ScheuerKenneth Offit
Jul 30, 2004·The New England Journal of Medicine·Mieke KriegeUNKNOWN Magnetic Resonance Imaging Screening Study Group
Sep 16, 2004·JAMA : the Journal of the American Medical Association·Ellen WarnerSteven A Narod
Dec 9, 2004·JAMA : the Journal of the American Medical Association·David A BluemkeMitchell D Schnall
Mar 2, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H F A VasenL Beex
Jun 24, 2005·AJR. American Journal of Roentgenology·Laura LibermanD David Dershaw
Nov 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christiane K KuhlHans H Schild
Dec 24, 2005·Radiology·Mitchell D SchnallConstantine A Gatsonis
Jun 16, 2006·Radiology·Petrina A CauserDonald B Plewes
Sep 16, 2006·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Dana R Rausch, R Edward Hendrick
Mar 10, 2007·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Doug HorsmanUNKNOWN National Hereditary Cancer Task Force
Mar 30, 2007·CA: a Cancer Journal for Clinicians·Debbie SaslowUNKNOWN American Cancer Society Breast Cancer Advisory Group
Mar 20, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Rachel Z BigenwaldMartin J Yaffe

❮ Previous
Next ❯

Citations

Sep 30, 2014·Academic Radiology·Haydan SmithJunjia Jay Zhu
May 27, 2017·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Michelle V LeeChristine O Menias
Mar 28, 2017·Breast Cancer Research and Treatment·Julia KrammerMaxine S Jochelson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.